Zobrazeno 1 - 5
of 5
pro vyhledávání: '"L K Kober"'
Autor:
L Ostergaard, M V Voldstedlund, N E B Bruun, H B U Bundgaard, K I Iversen, N K Kober, A D Dahl, S C H Chamat-Hedegaard, J K P Petersen, A D J Jensen, C M Moser, L K Kober, E L F Fosbol
Publikováno v:
European Heart Journal. 43
Background Staphylococcus aureus bacteremia (SAB) may be community acquired or healthcare acquired, and prior small studies have suggested that the place of acquisition impacts the subsequent prevalence of infective endocarditis (IE) and also patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80eead244e67ba4de807da2d99ff5ee1
https://doi.org/10.1093/eurheartj/ehac544.1665
https://doi.org/10.1093/eurheartj/ehac544.1665
Autor:
D Zahir, C M Madelaire, E F Fosboel, L K Kober, G G Gislason, C G Garred, A N B Bonde, C A Andersson, M S Schou
Publikováno v:
European Heart Journal. 43
Background Renal endpoints like end stage renal disease (ESRD) and a 50% decline in estimated glomerular filtration rate (eGFR) have been used in recent randomized clinical trials in heart failure (HF). However, the distribution of these events in la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0297d02583f39c3a1e6dcf4ea961b23f
https://doi.org/10.1093/eurheartj/ehac544.877
https://doi.org/10.1093/eurheartj/ehac544.877
Autor:
S A A Ali, M E Ersboll, N J V Vinding, J H B Butt, R R Rorth, C S Selmer, L M W Westergaard, U M M Mogensen, P E W Weeke, C J Jons, F G Gustafsson, E F Fosbol, L K Kober, S L K Kristensen
Publikováno v:
European Heart Journal. 43
Background Although thyroid dysfunction is a well-known complication of amiodarone treatment, population-based estimates of the short- and long-term incidence of this complication are lacking. In addition, it is not clear whether heart failure (HF) e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a59bdc79a0a7931203d7eb84e437f4
https://doi.org/10.1093/eurheartj/ehac544.431
https://doi.org/10.1093/eurheartj/ehac544.431
Autor:
L P Poulsen, Christian Torp-Pedersen, Tarec Christoffer El-Galaly, Emil L. Fosbøl, Kristian Kragholm, J W D Shanmuganathan, Bhupendar Tayal, L K Kober, Peter Søgaard, G G Gislason, Philip Freeman
Publikováno v:
European Heart Journal. 40
Abstract Background 5-fluorouracil (5-FU) is the third most commonly used chemotherapeutic agent in the treatment of solid malignancies across the world. The most common manifestation of cardiotoxicity associated with 5-FU is chest pain, presenting a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2c25817cd6be8d318ffce58b01731cd
https://doi.org/10.1093/eurheartj/ehz747.0075
https://doi.org/10.1093/eurheartj/ehz747.0075
Autor:
L O Ostergaard, N V Valeur, A W Wang, H B Bundgaard, M S Aslam, G G Gislason, C T P Torp-Pedersen, N E B Eske Bruun, L S Sondergaard, L K Kober, E L F Fosbol
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6696e1172a3a939b6b7052492639006e
https://doi.org/10.1093/eurheartj/ehy563.p4190
https://doi.org/10.1093/eurheartj/ehy563.p4190